Trial Profile
A Comparative Study of Dexmedetomidine and Propofol As Sole Sedative Agent for Patients With End-Stage Renal Disease Undergoing Arteriovenous Fistula Surgery
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Propofol
- Indications Sedation
- Focus Adverse reactions
- 20 May 2015 New trial record